Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Herzfeld Caribbean Basin Fund | CUBA | Nov 22, 2024 | 2.43 | -0.41 |
The Honest Company | HNST | Nov 22, 2024 | 8.15 | +6.54 |
The Intergroup | INTG | Nov 22, 2024 | 13.81 | -1.22 |
The J.M Smucker Company | SJM | Nov 22, 2024 | 113.30 | -0.52 |
The Joint | JYNT | Nov 22, 2024 | 11.75 | +1.56 |
The Marygold Companies | MGLD | Nov 22, 2024 | 1.48 | -4.52 |
The ODP | ODP | Nov 22, 2024 | 27.26 | +2.37 |
The OLB Group | OLB | Nov 22, 2024 | 1.95 | -1.52 |
The Oncology Institute | TOI | Nov 22, 2024 | 0.15 | -0.65 |
The ONE Group Hospitality | STKS | Nov 22, 2024 | 3.43 | +3.94 |
The Pennant Group | PNTG | Nov 22, 2024 | 31.14 | +2.10 |
The Real Brokerage | REAX | Nov 22, 2024 | 5.34 | +2.30 |
The Real Estate Select Sector SPDR Fund | XLRE | Nov 22, 2024 | 44.09 | +0.75 |
The RealReal | REAL | Nov 22, 2024 | 4.74 | +5.80 |
The RMR Group A | RMR | Nov 22, 2024 | 22.01 | -0.63 |
The Shyft Group | SHYF | Nov 22, 2024 | 13.78 | +3.77 |
The Trade Desk A | TTD | Nov 22, 2024 | 129.70 | +1.85 |
The9 ADR | NCTY | Nov 22, 2024 | 11.06 | +4.73 |
TherapeuticsMD | TXMD | Nov 22, 2024 | 1.37 | +3.01 |
Theratechnologies | THTX | Nov 22, 2024 | 1.20 | -0.83 |
Theravance Biopharma | TBPH | Nov 22, 2024 | 9.47 | -1.46 |
Theriva Biologics | TOVX | Nov 22, 2024 | 1.28 | 0.00 |
Thermo Fisher Scientific | TMO | Nov 22, 2024 | 513.26 | -0.55 |
Thermon Group | THR | Nov 22, 2024 | 31.97 | +2.53 |
Third Coast Bancshares | TCBX | Nov 22, 2024 | 36.12 | +2.41 |
Third Harmonic | THRD | Nov 22, 2024 | 12.47 | +8.91 |
Thomson Reuters | TRI | Nov 22, 2024 | 161.20 | -0.40 |
Thor Industries | THO | Nov 22, 2024 | 112.18 | +1.49 |
Thornburg Income Builder Opportunities Fund | TBLD | Nov 22, 2024 | 16.53 | +0.43 |
Thoughtworks | TWKS | Nov 22, 2024 | 4.47 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.